These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Comparative observations on the effect of folic acid and liver extract in the treatment of pernicious anemia and funicular myelosis]. KLIMA R; WENGRAF G Wien Med Wochenschr; 1950 Mar; 100(11/12):210-3. PubMed ID: 15413318 [No Abstract] [Full Text] [Related]
47. On the therapeutic effect of sulfonoxymannitol in chronic myelosis. GRAF F; TAKACSI-NAGY L Ther Hung; 1962; 10():8-10. PubMed ID: 13949742 [No Abstract] [Full Text] [Related]
48. [On the relation between polycythemia vera and chronic myelosis]. SHERMAN SI; ROZANOVA LM Ter Arkh; 1962 Mar; 34():99-104. PubMed ID: 13911730 [No Abstract] [Full Text] [Related]
49. Combined x-ray and myleran treatment of chronic myelosis. SVOBODA V Neoplasma; 1959; 6():295-304. PubMed ID: 13835984 [No Abstract] [Full Text] [Related]
50. [Colcemid and myleran in the treatment of chronic myelosis]. WILDHACK R Dtsch Med Wochenschr; 1957 Mar; 82(10):342-6. PubMed ID: 13427505 [No Abstract] [Full Text] [Related]
51. [Influence of leukocytes on binding capacity of thrombus in chronic leukemic myelosis]. HORDER MH; PILEGGI J Acta Haematol; 1957 Feb; 17(2):111-5. PubMed ID: 13410505 [No Abstract] [Full Text] [Related]
52. [Clinical manifestations of kidney diseases in chronic myelosis]. RADONIC M Acta Med Iugosl; 1956; 10(1):122-35. PubMed ID: 13372186 [No Abstract] [Full Text] [Related]
53. [Study of osmotic erythrocyte resistance in erythremic myelosis]. CASULA D Rass Med Sarda; 1950 May; 52(5):290-2. PubMed ID: 14786487 [No Abstract] [Full Text] [Related]
54. [Polymorphic cutaneous, oral and retinal manifestations in a case of leukemic myelosis]. SANGIUOLO F Riforma Med; 1950 Jan; 64(3):74-80. PubMed ID: 15417999 [No Abstract] [Full Text] [Related]
55. [A case of eosinophilic leukemic myelosis]. PIROVANO L Policlinico Prat; 1955 Nov; 62(46):1547-54. PubMed ID: 13289372 [No Abstract] [Full Text] [Related]
56. [On the problem of differential diagnosis of chronic myelosis from leukemoid reactions]. GINGOLD N; TEITEL P Probl Gematol Pereliv Krovi; 1959 Sep; 4():28-9. PubMed ID: 13850202 [No Abstract] [Full Text] [Related]
57. [CUTANEOUS INVOLVEMENT IN LEUKOSES: CHRONIC MYELOSIS WITH SPECIFIC CUTANEOUS INITIAL CLINICAL MANIFESTATIONS]. FAZZINI PF Arch De Vecchi Anat Patol; 1963 Dec; 41():923-39. PubMed ID: 14215161 [No Abstract] [Full Text] [Related]
58. [The extramedullary dissemination and clinical manifestations of myelosis]. FRESEN O Arztl Forsch; 1955 Oct; 9(10):I/451-9. PubMed ID: 13282776 [No Abstract] [Full Text] [Related]
59. Extramedullary megakaryocytosis in chronic myelosis. SCHWARZ E Am J Clin Pathol; 1954 Jun; 24(6):629-51. PubMed ID: 13158294 [No Abstract] [Full Text] [Related]
60. [The different behavior of colchicine and colcemid (demecolcine) in the therapy of chronic myelosis]. KEIBL E Wien Klin Wochenschr; 1955 Jul; 67(28):511-5. PubMed ID: 13247877 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]